Voloridge Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $97.9M | Buy |
436,314
+309,614
| +244% | +$77.2M | 0.39% | 52 |
|
|
2025
Q4 | $30.5M | Buy |
126,700
+119,664
| +1,701% | +$30.6M | 0.11% | 236 |
|
|
2025
Q3 | $1.93M | Buy |
+7,036
| New | +$1.92M | 0.01% | 942 |
|
|
2024
Q1 | – | Sell |
-3,318
| Closed | -$571K | – | 1323 |
|
|
2023
Q4 | $571K | Sell |
3,318
-659,039
| -99% | -$101M | ﹤0.01% | 1018 |
|
|
2023
Q3 | $97.9M | Buy |
662,357
+478,164
| +260% | +$86.5M | 0.48% | 35 |
|
|
2023
Q2 | $40.2M | Buy |
184,193
+86,589
| +89% | +$19.3M | 0.19% | 145 |
|
|
2023
Q1 | $21.4M | Buy |
97,604
+73,931
| +312% | +$16M | 0.11% | 273 |
|
|
2022
Q4 | $4.93M | Buy |
23,673
+21,670
| +1,082% | +$4.76M | 0.03% | 643 |
|
|
2022
Q3 | $437K | Sell |
2,003
-387
| -16% | -$88.1K | ﹤0.01% | 1284 |
|
|
2022
Q2 | $501K | Sell |
2,390
-6,423
| -73% | -$1.37M | ﹤0.01% | 1299 |
|
|
2022
Q1 | $2.14M | Sell |
8,813
-22,986
| -72% | -$5.56M | 0.01% | 925 |
|
|
2021
Q4 | $8.28M | Sell |
31,799
-20,641
| -39% | -$5.36M | 0.05% | 524 |
|
|
2021
Q3 | $13.8M | Sell |
52,440
-6,613
| -11% | -$1.81M | 0.09% | 309 |
|
|
2021
Q2 | $14.6M | Buy |
59,053
+27,567
| +88% | +$5.8M | 0.1% | 264 |
|
|
2021
Q1 | $6.11M | Buy |
31,486
+20,359
| +183% | +$4.08M | 0.04% | 463 |
|
|
2020
Q4 | $2.37M | Buy |
+11,127
| New | +$2.22M | 0.02% | 674 |
|
|
2020
Q2 | – | Sell |
-3,520
| Closed | -$518K | – | 1462 |
|
|
2020
Q1 | $518K | Sell |
3,520
-132,350
| -97% | -$21.1M | 0.01% | 701 |
|
|
2019
Q4 | $21.1M | Buy |
135,870
+71,554
| +111% | +$10.3M | 0.41% | 41 |
|
|
2019
Q3 | $8.69M | Buy |
64,316
+56,738
| +749% | +$7.43M | 0.15% | 153 |
|
|
2019
Q2 | $925K | Sell |
7,578
-27,509
| -78% | -$3.05M | 0.03% | 472 |
|
|
2019
Q1 | $3.65M | Buy |
35,087
+31,394
| +850% | +$3.24M | 0.11% | 184 |
|
|
2018
Q4 | $421K | Buy |
+3,693
| New | +$396K | 0.02% | 348 |
|
|
2018
Q2 | – | Sell |
-80,600
| Closed | -$7.94M | – | 577 |
|
|
2018
Q1 | $7.94M | Buy |
80,600
+71,340
| +770% | +$6.74M | 0.19% | 99 |
|
|
2017
Q4 | $784K | Buy |
+9,260
| New | +$765K | 0.02% | 390 |
|
|
2016
Q4 | – | Sell |
-62,122
| Closed | -$4.03M | – | 663 |
|
|
2016
Q3 | $4.03M | Buy |
+62,122
| New | +$4.13M | 0.09% | 123 |
|
|
2016
Q2 | – | Sell |
-62,354
| Closed | -$3.6M | – | 386 |
|
|
2016
Q1 | $3.6M | Buy |
+62,354
| New | +$3.53M | 0.08% | 163 |
|
|
2015
Q4 | – | Sell |
-7,434
| Closed | -$379K | – | 285 |
|
|
2015
Q3 | $379K | Buy |
+7,434
| New | +$400K | 0.02% | 252 |
|
Other funds holding RMD
VCM
VPM
DAM
Voloridge Investment Management's RMD Position: Q1 2026 in Review
Voloridge Investment Management increased its ResMed (RMD) stake by 244% in Q1 2026, buying an estimated $77.2M and bringing the position to 436,314 shares worth $97.9M. The position accounts for 0.39% of the portfolio, ranked #52.
Voloridge Investment Management first reported a position in RMD in Q3 2015 and has held it in 27 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Voloridge Investment Management held 436,314 shares of ResMed worth $97.9M as of Q1 2026.
- Voloridge Investment Management bought 309,614 ResMed shares in Q1 2026, an estimated $77.2M.
- ResMed made up 0.39% of Voloridge Investment Management's portfolio in Q1 2026, its #52 holding.
- Voloridge Investment Management first reported a position in ResMed in Q3 2015 and has held it in 27 quarters since.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.